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Abstract
Background: Data regarding HIV-seronegative pediatric patients with cryptococcal meningitis (CM) have been very limited.
Methods:We retrospectively reviewed non-HIV-infected in patients with CM from January 2002 through December 2013 in
Beijing Children’s Hospital. Records of the all patients were obtained and compared.
Results: The 34 children had a median age of 5.6 years. Most of the patients were male (67.6 %). Only 23.5 % of the cases
had identifiable underlying diseases. The sensitivity of the CSF cryptococcal antigen, India ink smear and CSF culture in our
study were 81.5, 85.3 and 82.4 %, respectively. And the sensitivity of combinations of these tests was 91.2 %. Out of the 34
patients, 16 (47.1 %) had other organs involvement in addition to the brain. The main abnormal features via magnetic
resonance imaging (MRI) were Virchow-Robin space dilatation (44.4 %), hydrocephalus (38.9 %), gelatinous pseudocysts
(33.3 %), brain atrophy (33.3 %), meningeal enhancement (27.8 %) and local lesions (27.8 %). In total, 64.7 % of the patients
were successfully treated at discharge, whereas treatment failed in 35.3 % of the patients.
Conclusions: Cryptococcal meningitis is an infrequent disease with a high fatality rate in children in China. The majority of
patients were apparently healthy. Clinicians should consider cryptococcal infection as a potential pathogen of pediatric
meningitis. Cryptococcal antigen, India ink smear and culture tests are recommended for diagnosis.
Background
Cryptococcal meningitis (CM) is the most common fungal
infection of the central nervous system and has a high
morbidity and mortality. Globally, approximately 957,900
cases of CM occur annually, resulting in 624,700 deaths
within 3 months after infection [1]. Many large studies
have been conducted in adults, but few studies have been
dedicated to pediatric patients. On the basis of these
limited data, the incidence of cryptococcosis in children
was 0.016–100 cases/100,000 children [2]. The average
annual incidence of CM was found to be 0.43/100,000 in
China [3]. Reported pediatric patients only account for
2 % of all cryptococcal cases [4] but could potentially
result in higher morbidity and mortality [5]. Furthermore,
the average annual incidence of CM is less frequent
especially in non-HIV (human immunodeficiency virus)
pediatric population [1–3, 6–9]. Human immunodefi-
ciency virus (HIV) infection is a main risk factor and
accounts for 95 % of CM cases in middle- and low-
income countries and 80 % of CM cases in high-income
countries [7, 8]. However, the majority of adult patients
with CM in China are apparently healthy (66.9 %) [9].
Data regarding predisposed and normal in children have
been very limited. Here, we present a single-center study
of CM in non-HIV-infected pediatric patients with a
comprehensive analysis of clinical features and outcomes.
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We retrospectively reviewed non-HIV-infected in patients
with CM from January 2002 through December 2013 in
Beijing Children’s Hospital (a 970-bed tertiary health care
hospital), China. Records of all of the patients with CM
during a 12-year period were obtained. Demographic data,
underlying diseases, clinical features in the patients’ his-
tory, laboratory findings, cranial imaging, antifungal treat-
ments and outcomes were analyzed.
Definitions
Diagnosis of cryptococcal meningitis
A definite diagnosis of CM was determined if the patient
met at least one of the following criteria [10]; (1) positive
culture of Cryptococcus from cerebrospinal fluid (CSF), (2)
positive India ink smear of CSF centrifuged sediment for
Cryptococcus, or (3) positive cryptococcal antigen findings
in the CSF and/or in the blood.
Cryptococcal antigen assay
The Immy Latex-Crypto Antigens (Immuno-Mycologics,
Inc.) were used to perform the antigen assay.
Normal and predisposed hosts
Patients with one or more predisposing factors, such as
underlying diseases (nephrotic syndrome, Henoch-Schon
leinpurpura, juvenile rheumatoid arthritis, pyothorax,
lung tuberculosis, X-linked agammaglobulinemia (XLA),
hepatitis B virus infection, or congenital heart disease),
were classified as predisposed hosts. Patients with no
identifiable underlying diseases were classified as previ-
ously healthy hosts.
The severity of fever
A low degree of fever indicates a temperature between
37.4 and 38 °C; a moderate degree of fever indicates a
temperature between 38 and 39 °C; and a high degree of
fever indicates a temperature more than 39 °C.
Outcomes
Major outcomes could be in-hospital all-cause mortality
and mortality at 6-months; and minor outcomes are CSF
sterilization rate after the induction phase, the proportion
of neurologicalsequelae (hearing and visual impairment)
after the onset of disease and the length of hospitalization.
Long-term outcomes were assessed via telephone at the
end point of follow-up.
Statistical analysis
Mean and standard deviations (SDs) are shown when
distributions were confirmed normal; median and inter-
quartile range (IQRs) are reported otherwise. The categor-
ical variables were compared using the Chi-square test or
Fischer’s exact test, as appropriate. Continuous variables
within two groups were compared using the independent t-
test for parametric data and the Mann-Whitney U test for
non-parametric data. P values <0.05 were considered
statistically significant. All of the statistical analyses were
conducted using SPSS 17.0 (SPSS Inc., USA).
Results
Overall, 34 HIV-negative children with CM were enrolled
in this study.
Baseline characteristics of the patients
The median onset age was 5.6 (range 1.6, 12.6) years and
88.2 % of the children were more than three years old.
Twenty-three patients were male (67.6 %) and from a
rural area (76.5 %). The male/female ratio was 2.09:1. Half
of the patients (50 %) obtained the disease in the summer
(June-August) during the 12-year period. Nearly half of
the patients (44.1 %) had contact history with birds before
the onset of illness. All of the children were Han people.
The patients were from 10 provinces and districts of
China; the largest subset of the population came from
Hebei province. The numbers of cases were evenly distrib-
uted over the 12-year period with four cases every year
apart from 2012 when there were eight cases (Fig. 1).
The median time from symptom onset to diagnosis was
30 (interquartile range 17, 54) days. In six cases (17.6 %),
symptoms appeared less than two weeks before the
diagnosis of CM, whereas in 23 patients (67.6 %), symp-
toms appeared between two weeks to two months prior to
diagnosis. The other five patients (14.7 %) displayed
symptoms more than two months prior to diagnosis. Of
the participants, 70.6 % (24 cases) of the children were
misdiagnosed as having other diseases before admission to
our study, with tuberculosis (11/24, 45.8 %) accounting
for the majority of these other diagnoses.
Predisposing factors
All of the children were confirmed to be non-HIV infected
by negative serum HIV antibodies. Only 8 cases (23.5 %)
had identifiable underlying diseases. The following
immunocompromising conditions were found in one of
each of those eight cases: nephrotic syndrome, Henoch-
Schonleinpurpura, juvenile rheumatoid arthritis, pyothorax,
lung tuberculosis, X-linked agammaglobulinemia (XLA),
hepatitis B virus infection, or congenital heart disease. The
remaining 26 (76.5 %) patients were apparently healthy with
basically normal levels of immunoglobulins and T cell sub-
sets (CD4+ Tcells and CD8+ Tcells). The CD4+ T lympho-
cyte count of all the patients were more than 500/mm3.
Signs and symptoms
All of the patients had fever, which was the most common
symptom, with 5.9 % (2 cases) presenting a low degree,
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35.3 % (12 cases) presenting a moderate degree, and
58.8 % (20 cases) presenting a high degree. Other com-
mon clinical manifestations included nausea (22 cases,
64.7 %), headache (21 cases, 61.8 %), vomiting (21 cases,
61.8 %), meningeal signs (18 cases, 52.9 %) and neck
stiffness (16 cases, 47.1 %). Eleven patients (32.4 %)
presented with altered mental status, consciousness or
fundus changes. Cranial nerve palsies were observed in 10
(29.4 %) cases involving the optic nerve, oculomotor nerve
and facial nerve. Ten cases (29.4 %) experienced seizures,
including five patients who had grand mal seizures. Five
patients (14.7 %) presented limb weakness.
Laboratory data
Blood findings
The median white blood cell (WBC) count in the blood
was 10.5 (interquartile range 8.6, 14.9) × 109/L with a
predominance of neutrophils. 52.2 % of the patients had
eosinophilia with the median eosinophil 1.07 (interquar-
tile range 0.3, 1.24) × 109/L. The median CRP was
15.6 mg/L with a maximum of 150 mg/L (inflammation
was evaluated with a test that measured levels in excess
of 8 mg/L). The erythrocyte sedimentation rate (ESR)
was 46.5 ± 30.2 mm/h, and 18/29 (62.1 %) of the patients
had elevated IgE levels. There were not any other clinical
features of these in the children with eosinophilia and
raised IgE, like recurrent boils, rashes etc., indicating
that there was no suspected Hyperimmunoglobulin E
Syndrome (Job’s syndrome) patients.
Cerebrospinal fluid (CSF) findings
All of the patients underwent lumbar puncture. 27/34
(79.4 %) had the medical records of CSF opening pres-
sure .55.6 % (15/27) of the patients had high CSF open-
ing pressure (>200 mmH2O) and the other 12 patients
had normal CSF opening pressure. 8/15 (53.3 %) had the
values records, 75 % (6/8) of the patients > 300 mmH2O,
the other two patients’ values were between 200 ~ 300
mmH2O. The median WBC count in the CSF was 31
(interquartile range 9, 100) × 106/L, with 67.6 % (23
cases) having pleocytosis. The median CSF glucose
concentration was 2.38 ± 1.41 mmol/L, and 67.6 % (23
cases) had below normal levels (2.8 mmol/L). Seven of
the 34 (20.6 %) patients had the ratio of CSF to plasma
glucose at the meantime, and 42.9 % (3/7) of those
patients had a CSF: glucose ratio that was less than 50 %
of their plasma. The median CSF protein concentration
was 585 (interquartile range 361, 860) mg/L, with 64.7 %
(22 cases) having above normal levels (450 mg/L).
Neuroradiological manifestation
Eighteen and 17 cases underwent cranial MRI or CT scans,
respectively. All of the patients had abnormal results.
Among these, the main radiological features via MRI were
Virchow-Robin space dilatation (8/18, 44.4 %), hydroceph-
alus (7/18, 38.9 %), gelatinous pseudocysts (6/18, 33.3 %),
brain atrophy (6/18, 33.3 %), meningeal enhancement (5/
18, 27.8 %) and local lesions (5/18, 27.8 %). Common sites
of Virchow-Robin space dilatation and gelatinous pseudo-
cysts were the basal ganglia region and corona zone. The
MRI scans also detected two cases of granuloma. We
found that 90 % of the patients (9/10) had abnormal re-
sults as detected by magnetic resonance venography
(MRV), mostly as transverse sinus and sigmoid sinus slim
or discontinuous imaging. The vast majority of the pa-
tients obtained normal magnetic resonance angiography
(MRA) results, whereas only two cases had a thinner mid-
dle cerebral artery. In contrast to MRI, common abnormal
results for CT scans were hydrocephalus (9/17, 52.9 %)
and brain atrophy (11/17, 64.7 %) without Virchow-Robin
space dilatation and gelatinous pseudocysts.
Fig. 1 Number of cryptococcal meningitis cases diagnosed per year. The number of cases diagnosed remained constant each year except for 2012
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Electroencephalogram
In 12 cases, the patients underwent an electroencephalo-
gram test, and seven cases (58.3 %) had abnormal results
with varying slow wave levels.
Pathogen findings
The sensitivity of the CSF cryptococcal antigen, India
ink smear and CSF culture in our study were 81.5, 85.3
and 82.4 %, respectively. And the sensitivity of combina-
tions of these three tests was 91.2 %. Of these, 88.2 %
(30/34) of cases obtained positive results in the first
three lumbar punctures. One patient obtained positive
results in the ninth lumbar punctures. We had three pa-
tients who had all negative results of these three patho-
gen tests in the CSF, but had positive results antigens for
Cryptococcus in the blood (Table 1).
Other organs involvement
Sixteen of the 34 patients (47.1 %) had other organs in-
volvement in addition to the brain. All but one patient
had lung involvement. Other organs included the liver,
spleen, lymph node, renal and bone marrow. Infections
were diagnosed in two patients by mesentery lymph
node histopathology and sputum sampling, respectively.
Initial antifungal therapy and outcomes
Four initial antifungal regimens were prescribed to the
patients. A combination of amphotericin B and flucona-
zole, with or without flucytosine for 12 cases accounted for
the first regimen, followed by fluconazole with or without
flucytosine for 10 cases, and amphotericin B for five cases.
Seven more patients were administered other treatments
including amphotericin B colloidal dispersion, itraconazole,
voriconazole, and others. Amphotericin B was given
intrathecally to 11 patients (32.4 %) during hospitalization.
Ventricular drainage or lumbar drainage was performed in
two cases (5.9 %). Three patients (8.8 %) were transferred
to the pediatric intensive care unit because of disease
deterioration; two of these patients experienced mechanical
ventilation. Two cases (5.9 %) experienced cerebral
herniation during the hospitalization, three cases (8.8 %)
had renal injury and 16 cases (47.1 %) had hypokalemia. In
those patients who took amphotericin B therapy, 85.7 % of
patients had anemia, 44.4 % had elevated aminotransferase
and 15.4 % had neutropenia. There was no patient died in
the hospital. Of all of the patients, 22 (64.7 %) obtained a
successful outcome at discharge; half of those patients had
a complete response, and the other half had a partial re-
sponse. However, 12 cases (35.3 %) experienced failure re-
sults, with six cases having stable or progressive status at
the time of discharge. CSF sterilization rate after the induc-
tion phase was 13.6 % (3/22). Fifteen patients under went
followed up for a median time of two years. Seven patients
(46.7 %) had a poor outcome at the endpoint, five of these
patients (33.3 %) died, and two (13.3 %) were left with an
altered mental status and visual impairment. Eight patients
(53.3 %) recovered with no complications. No patients pro-
gressed to epilepsy. Compared to the survival group and
the death group, the patients in death group were more
likely to have neck stiffness (100 vs. 30 %, P < 0.05). The
patients in survival group had higher ESR and eosinophil
than patients in death group. There were no significant dif-
ferences in baseline characteristics such as age, area, con-
tact history, time to diagnosis, hospitalization, daily cost
and CSF tests (Table 2).
Comparison between normal and predisposed hosts
There were 26 (76.5 %) normal host patients and eight
(23.5 %) cases in the predisposed host group. The pa-
tients in the two hosts groups showed no significant dif-
ferences in baseline characteristics such as age, area,
contact history, time to diagnosis, hospitalization, daily
cost and prognosis both at discharge and follow-up. In
terms of manifestations, compared to normal hosts, the
patients who had underlying diseases were more prone
to having an altered mental status (62.5 vs. 19.2 %, P <
0.05) and seizures (62.5 vs. 15.4 %, P < 0.05). The pa-
tients in the normal hosts group had a higher ESR than
patients in the predisposed hosts group. Other routine
CSF and chemistry tests as well as blood findings had
similar results in the two host groups (Table 3).
Discussion
The central nervous system is the main involved area in
cryptococcosis disease both in pediatric and adults’ popula-
tion. Data showed that there was 83.4 % of central nervous
system involvement in 8769 cases of cryptococcosis in
China from 1985 to 2010 [11] and 87.1 % of the pediatric
cases had central nervous system involvement in China [4].
However, this is less frequent pediatric cases reported,
particularly in non-HIV patients [1–3, 6–9]. Reported
pediatric patients only account for 2 % of all cryptococcal-
cases [4] but could potentially result in higher morbidity
and mortality rates [5].
In our study, 67.6 % of the patients were boys. This is
similar to other hospital-based reports of CM in both









(%) (N = 34)
1st 20 (74.1) 9 (26.5) 11 (32.4) 26 (76.5)
2nd 22 (81.5) 20 (58.9) 16 (47.1) 29 (85.3)
3rd 22 (81.5) 23 (67.6) 22 (64.7) 30 (88.2)
>3rd 22 (81.5) 29 (85.3) 28 (82.4) 31 (91.2)
Negative 5 (18.5) 5 (14.7) 6 (17.6) 3 (8.8)
Total 27 (100) 34 (100) 34 (100) 34 (100)
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adults and children with male predominance [2, 3, 12–17].
Why there is a male predominance in patients with CM is
an interesting question requiring further evaluation. In our
series, most of the patients were from rural areas with a
history of contacting birds. Guo Jiahua reported that 73.9
and 73.26 % of infected children were from rural areas and
had a history of avian contact in Shi Jiazhuang, China [3].
Similar results were also obtained in a population-based
study in Australia and New Zealand [18]. The reason for
this phenomenon is unknown but may partly be due to in-
creased environmental exposure.
The median age of the infected children was approxi-
mately 5.6 years old in the current study, and only three
cases were younger than two years of age consistent with
prior studies of CM in non-HIV children [2, 3, 15, 18].
Only 3 % of the cases in the reported literature and 9.5 %
of new patients are younger than 2 years [19]. This finding
could be explained by the increase in the mobility and
independence of children, resulting in increased environ-
mental exposure.
In our study, 52.2 and 62.1 % of the patients had an eo-
sinophilia or elevated IgE level, respectively. There were not
any other clinical features of these in the children with
eosinophilia and raised IgE, indicating that there was no
suspected Hyperimmunoglobulin E Syndrome. Although
eosinophilia has been reported in HIV-negative crypto-
coccal infection patients, it is still relatively rare [11, 20–23].
Yamaguchi reported a 23-year-old patient was diagnosed as
disseminated cryptococcosis including meningitis with very
marked eosinophilia (75 %). And the eosinophilia was
successfully alleviated by treatment for cryptococcal menin-
gitis [24]. In addition, infections presenting with elevated
Table 2 Comparison between the survival group and the death






Age (year) 6 (4–10) 8 (5–10) 0.624
Sex (Male:Female) 3:2 1:4 0.282
Area (rural) 6 (60) 5 (100) 0.231
Contacting history 5 (50) 2 (40) 1.000
Predisposed hosts 4 (40) 2 (40) 1.000
Time to diagnosis (day) 28 ± 13 24 ± 20 0.732
Hospitalization (day) 53 ± 28 25 ± 23 0.084
Daily cost (RMB) 1258 (685–2502) 1304 (1187–2321) 0.540
Manifestations
Fever 39.3 (38.6–39.8) 38.5 (38.5–39.2) 0.156
Headache 5 (50) 4 (80) 0.580
Vomiting 6 (60) 5 (100) 0.231
Altered mental status 1 (10) 3 (60) 0.077
Seizure 3 (30) 4 (80) 0.119
Vision damage 3 (30) 2 (40) 1.000
Neck stiffness 3 (30) 5 (100) 0.026*
Fundus abnormality 2 (25) 2 (100) 0.133
CSF
CSF WBC (×106/L) 24.5 (7.5–91.0) 16.0 (2.0–69.0) 0.581
Glu (mmol/L) 2.82 (1.88–3.76) 2.80 (1.54–5.40) 0.903
Pro (mg/L) 523 (333–856) 361(170–1492) 0.806
Blood
WBC (×109/L) 10.4 (8.6–18.2) 10.7 (9.0–12.1) 0.806
CRP (mg/L) 29.8 (7.8–41.6) 11.9 (1.7–54.5) 0.315
ESR (mm/h) 51 (44–76) 24 (16–31) 0.042*
EO (×109/L) 1.37 (0.55–2.81) 0.2 (0.07–1.05) 0.040*
*P < 0.05
Table 3 Comparison between the predisposed hosts and








Age (year) 5 (3–9) 7 (4–10) 0.900
Sex (Male: Female) 19:7 1:1 0.388
Area (rural) 21 (80.8) 5 (62.5) 0.355
Contacting history 10 (38.5) 5 (62.5) 0.417
Time to diagnosis (day) 30 (20–56) 25 (13–56) 0.759
Hospitalization (day) 41 ± 25 53 ± 44 0.352
Daily cost (RMB) 846 (567–1615) 1080 (621–1080) 0.138
Disseminated
cryptococcosis
14 (53.8) 2 (25.0) 0.233
Manifestations
Fever 39.2 ± 0.7 38.9 ± 0.8 0.242
Headache 14 (53.8) 7 (87.5) 0.116
Vomiting 14 (53.8) 7 (87.5) 0.116
Altered mental status 5 (19.2) 5 (62.5) 0.031*
Seizure 4 (15.4) 5 (62.5) 0.017*
Vision damage 4 (15.4) 4 (50.0) 0.066
Neck stiffness 13 (50.0) 5 (62.5) 0.693
Blood
WBC (×109/L) 12.4 (8.6–16.3) 10.2 (8.8–11.3) 0.274
CRP (mg/L) 11.9 (0–63.5) 16 (0–30.9) 0.592
ESR (mm/h) 50 (26–79) 10 (1–52) 0.037*
EO (×109/L) 0.72 (0.31–1.77) 0.38 (0.2–1.24) 0.504
CSF
WBC (×106/L) 32 (10–113) 25 (7–102) 0.313
Glu (mmol/L) 2.24 ± 1.23 2.80 ± 1.92 0.332
Pro (mg/L) 625 (436–890) 660 (386–938) 0.528
Prognosis
Success at discharge 16 (61.5) 6 (75.0) 0.618
Success at follow-up 4/10 (40.0) 3/5 (60.0) 0.608
*P < 0.05
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IgE have been associated with a high risk of systemic
cryptococcal dissemination, including meningitis [25, 26].
Th2-dominant immune status has been reported to cause
increases in serum IgE, as well as susceptibility to crypto-
coccal infections [27].
In terms of clinical symptoms and signs, in the current
study, fever was the most frequent symptom, followed by
nausea, vomiting, headaches, meningeal signs, neck
stiffness, altered mental status and consciousness, seizure
and cranial nerve palsies. Visual and hearing impairment
were less common. These results were similar to those de-
scribed in the literature [3, 9, 15, 18]. Pleocytosis, elevated
CSF proteins, and decreased CSF glucose levels were also
common. Such findings are also consistent with previous
reports of cryptococcosis in non-HIV-infected children by
Guo and Zhu [3, 15, 18].
Notably, 70.6 % of the children were diagnosed as having
other diseases before admission in our study, with
tuberculosis accounting for the most frequent misdiag-
nosis. It is unexpected that up to 70–100 % of CM patients
experienced misdiagnosis in previous studies, mostly as
tuberculosis-associated diseases [15]. CM is an important
differential diagnosis with tuberculosis. Moreover, it takes
a long time to diagnose this disease. Thus, the tests for
pathogen detection play an important role in helping
doctors make a definite diagnosis. The high sensitivity of
combinations with variety cryptococcal tests in our study
is encouraging. The sensitivity of the CSF cryptococcal
antigen, India ink smear and CSF culture in our study were
81.5, 85.3 and 82.4 %, respectively. Apparently, the India
ink stain, culture and cryptococcal antigen tests should be
performed in children suspected to have CM, even those
with normal cerebrospinal fluid and biochemical test
results.
Consistent with other studies, CM patients had poor
outcomes with a longer hospitalization duration despite
multi-antifungal treatments [3, 15]. 35.2 % of the
patients had no response at discharge and 33.3 % died
during the follow-up time. Therefore, CM in pediatric
populations remains a large challenge for pediatricians.
The proportion of immunocompetent patients with
CM varies among non-HIV-infected patients in different
regions and countries regardless of the age. Studies from
the U.S., France, and Thailand reported a relatively small
rate (17–35 %) of cryptococcosis occurring in patients
with an apparently healthy condition [8, 14, 28]. How-
ever, a significantly higher rate of cryptococcosis was re-
ported in immunocompetent individuals in China. In
our study, only 8 cases (23.5 %) had identifiable under-
lying diseases, and the remaining 26 (76.5 %) patients
were apparently healthy with basically normal levels of
CDs and immunoglobulins. This is consistent with other
studies. For example, among the 154 CM cases reported
at Huashan Hospital, Shanghai, 66.9 % cases were
identified in immunocompetent individuals [9]. Simi-
larly, 68 % of CM cases were reported in immunocom-
petent individuals in another study performed at
Changzheng Hospital, Shanghai [29]. In terms of the 23
HIV-negative children with CM in Shi Jiazhuang, China,
only 26.1 % of the cases had underlying diseases. A
population-based study reported that 61.9 % of crypto-
coccosis cases were from immunocompetent individuals
in Taiwan [30]. Furthermore, studies from other Asian
countries where Chinese is the predominant ethnic
group reported similar results. In a study on HIV-
uninfected patients with CM in Vietnam, 81 % (57
patients) had no clear predisposing factor [31]. Taken
together, these reports suggest that cryptococcosis
predominantly occurs in immunocompetent hosts in the
Chinese ethnic population, which may be more suscep-
tible to cryptococcal infections than other ethnic groups.
The reason for this phenomenon is not well known. Ou
et al. [32] performed a study regarding the association
between mannose-binding lectin (MBL) polymorphisms
and the development of CM in non-HIV Chinese pa-
tients. The authors found that the genotypes underlying
deficient MBL production were associated with CM in
the Chinese Han ethnicity, particularly in immunocom-
petent patients, suggesting that MBL deficiency is a gen-
etic predisposition to CM. Another investigation
revealed that FccRIIB polymorphisms are an important
genetic factor contributing to CM in HIV-uninfected
Chinese individuals [33].
To our knowledge, the present study is one of the
largest case series of CM in non-HIV pediatric patients
around world. However, this study has some limitations.
It was a single center, hospital-based retrospective
design, which introduces the possibility of unrecognized
biases, a high dropout rate and incomplete data
collection including CSF pressure measurements, EO
etc. Because of cryptococcal meningitis in non-HIV
pediatric population being relatively rare, we had a small
sample in the study and the small number of deaths
precluding multivariate analysis of factors influencing
mortality. We had no data regarding pathogen serotype
or molecular type. Thus, we would like to use our
central nervous system follow-up system to perform
more prospective studies in the future. Further multi-
center studies are necessary to enrich the generalizability
of CM in children.
Conclusions
CM is an infrequent disease with a high fatality rate in
children in China. The majority of patients were appar-
ently healthy. Clinicians should consider cryptococcal
infection as a potential pathogen of pediatric meningitis.
Cryptococcal antigen, India ink smear and culture tests
are recommended.
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